Mechanical Support Did Not Lower Heart Attack Risk
Prophylactic devices during complex heart procedures did not reduce major cardiovascular events in a new study.
Updated on Sept. 22, 2026 in Heart Disease
Live Poll
Do you trust that common medical support interventions during high-risk surgery always improve patient outcomes?
A network meta-analysis of 1,856 patients found that using mechanical circulatory support during percutaneous coronary intervention (PCI) did not lower the risk of major adverse cardiovascular events (MACE) at 30 days. These findings challenge common practices for high-risk patients undergoing cardiac procedures.
Why it matters
Understanding the efficacy of mechanical circulatory support is essential for clinicians evaluating the safety and necessity of prophylactic interventions. This meta-analysis helps clarify which strategies provide meaningful benefits during high-risk cardiac care.
In a network meta-analysis of eight randomized trials involving 1,856 patients (mean age 66), researchers found no reduction in 30-day major adverse cardiovascular events compared to standard care. While outcomes remained unchanged, the study noted that percutaneous LVAD and IABP reduced periprocedural complications.
The details
Researchers evaluated the use of percutaneous left ventricular assist devices (LVAD), intra-aortic balloon pumps (IABP), and venoarterial extracorporeal membrane oxygenation (VA-ECMO) during PCI. These devices are designed to maintain systemic circulation during procedures that may stress the heart. While they show a benefit in reducing periprocedural complications, they failed to improve the broader 30-day MACE outcomes compared to standard care.
Timeline
September 9, 2026: Study findings published online.
30 days: Follow-up period for MACE risk assessment.
10.8 months: Mean follow-up duration for MACE, stroke, and MI.
14.1 months: Mean follow-up duration for death risk.
Health Landscape
This research contributes to the ongoing refinement of the European Society of Cardiology clinical guidelines for myocardial revascularization. It provides a clearer data-driven perspective on the use of mechanical support in the current era of high-risk percutaneous interventions.
If you or a loved one are scheduled for a complex percutaneous coronary intervention, it is worth discussing the necessity of prophylactic support with your cardiologist. Understanding the distinction between periprocedural safety and long-term MACE risk is a vital part of your care planning.
The takeaway
While mechanical circulatory support can reduce complications occurring during the procedure itself, it may not prevent broader cardiovascular events in the month following treatment. Patients should prioritize discussing individual risk factors and expected outcomes with their cardiac specialist.
Further reading
For more on managing complex cardiac conditions, visit our Heart Disease section.
Source note: This article includes information reported by Medscape.
Live Poll
Do you trust that common medical support interventions during high-risk surgery always improve patient outcomes?
